The current spurt in diagnostic tests on dengue and chikungunya in areas like New Delhi will help Dr Lal PathLabs post good Q2 volumes, says Om Manchanda, Chief Executive of the healthcare firm.
first published: Aug 30, 2016 11:59 am
A collection of the most-viewed Moneycontrol videos.

Groww CEO Lalit Keshre on ₹62,000 Crore IPO, Sebi regulations, valuation expectation and more

How Income Plus Arbitrage Fund of Fund Can Help You Get Stable, Tax-Efficient Returns

Nifty fails to hold 26,000, slips below 25,900 | Closing Bell

Live: Will Nifty bulls take it to new highs after Fed outcome? | Opening Bell
You are already a Moneycontrol Pro user.

